Search
Descriptor English: Buprenorphine, Naloxone Drug Combination
Descriptor Spanish: Combinación Buprenorfina y Naloxona
Descriptor combinación medicamentosa de buprenorfina y naloxona
Entry term(s) Suboxone
Scope note: Preparación farmacéutica que combina buprenorfina, un ANALGÉSICO OPIOIDE, con naloxona, un ANTAGONISTA DE NARCÓTICO, para reducir la potencial DEPENDENCIA DE NARCÓTICOS en el tratamiento del dolor. También se puede utilizar para el TRATAMIENTO DE SUSTITUCIÓN DE OPIÁCEOS.
Descriptor Portuguese: Combinação Buprenorfina e Naloxona
Descriptor French: Association de buprénorphine et de naloxone
Entry term(s): Buprenorphine Naloxone
Buprenorphine Naloxone Combination
Buprenorphine Naloxone Drug Combination
Buprenorphine-Naloxone
Buprenorphine-Naloxone Combination
Buprenorphine-Naloxone Drug Combination
Combination, Buprenorphine-Naloxone
Combination, Buprenorphine-Naloxone Drug
Drug Combination, Buprenorphine-Naloxone
Naloxone, Buprenorphine
Suboxone
Tree number(s): D03.132.577.249.150.500
D03.132.577.249.706.275
D03.605.497.150.500
D03.605.497.750.275
D03.633.400.686.150.500
D03.633.400.686.750.275
D04.615.723.795.150.500
D04.615.723.795.706.275
D26.310.352
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000069479
Scope note: A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESICS with naloxone, a NARCOTIC ANTAGONISTS to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIOID SUBSTITUTION THERAPY.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Analgesics, Opioid
Narcotic Antagonists
Public MeSH Note: 2016; BUPRENORPHINE, NALOXONE DRUG COMBINATION was indexed under BUPRENORPHINE and NALOXONE 2006-2015
History Note: 2016 (2006)
DeCS ID: 55912
Unique ID: D000069479
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2019/03/27
Buprenorphine, Naloxone Drug Combination - Preferred
Concept UI M0498625
Scope note A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESICS with naloxone, a NARCOTIC ANTAGONISTS to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIOID SUBSTITUTION THERAPY.
Preferred term Buprenorphine, Naloxone Drug Combination
Entry term(s) Buprenorphine Naloxone
Buprenorphine Naloxone Combination
Buprenorphine Naloxone Drug Combination
Buprenorphine-Naloxone
Buprenorphine-Naloxone Combination
Buprenorphine-Naloxone Drug Combination
Combination, Buprenorphine-Naloxone
Combination, Buprenorphine-Naloxone Drug
Drug Combination, Buprenorphine-Naloxone
Naloxone, Buprenorphine
Suboxone - Narrower
Concept UI M0498624
Preferred term Suboxone



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey